<DOC>
	<DOCNO>NCT02463253</DOCNO>
	<brief_summary>This single-center , prospective , non-randomized , observational study evaluate specific proteogenomic biomarker panel acute rejection ( AR ) chronic allograft nephropathy/interstitial fibrosis tubular atrophy ( CAN/IFTA ) blood , urine kidney tissue ( biopsy ) kidney transplant recipient . Proteogenomic profile routinely monitor one year enrollment .</brief_summary>
	<brief_title>Correlation Molecular Biomarkers With Biopsy Findings Outcomes Renal Transplant Recipients</brief_title>
	<detailed_description>OBJECTIVE : The objective phase study allow clinical site gain familiarity patient recruitment , sample data collection , interpretation proteogenomic biomarker report provide , retrospective analysis . This phase study provide platform transplant physician gain confidence format , logistics , potential use biomarker test blood tissue .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<criteria>Patients meet follow criterion eligible enrollment study participant : 1 . Male female recipient race , â‰¥18 year age . 2 . Patients undergo primary subsequent deceaseddonor live donor kidney transplantation . 3 . Subject and/or guardian must able provide inform consent . 4 . Subject and/or guardian must able comply study protocol . 1 . Need combine organ transplantation extrarenal organ and/or islet cell transplant . 2 . Recipients previous nonrenal solid organ and/or islet cell transplantation 3 . Infection HIV . 4 . Inability unwillingness participant and/or guardian provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Renal Biopsy</keyword>
	<keyword>elevate serum creatinine</keyword>
	<keyword>proteinuria</keyword>
</DOC>